Concomitant G-CSF use in maintaining an efficacious dose and safe delivery of docetaxel in combination with darolutamide in patients with metastatic hormone sensitive prostate cancer (mHSPC): ARASENS, a phase 3 study. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Ong, Michael
  • Suzuki, Hiroyoshi
  • Smith, Matthew R
  • Tombal, Bertrand F
  • Hussain, Maha HA
  • Saad, Fred
  • Fizazi, Karim
  • Verholen, Frank
  • Pham, Ha
  • Srinivasan, Shankar
  • Lalani, Aly-Khan

publication date

  • February 10, 2025